US2022347255A1PendingUtilityA1

Compositions and methods for treatment of hereditary cystatin c amyloid angiopathy (hccaa) and other neurodegenerative disorders associated with aberrant amyloid deposits

64
Assignee: CHILDRENS HOSPITAL PHILADELPHIAPriority: Sep 7, 2017Filed: May 20, 2022Published: Nov 3, 2022
Est. expirySep 7, 2037(~11.1 yrs left)· nominal 20-yr term from priority
Inventors:Hakon HakonarsonAlvaro Gutierrez-UzquizaMichael March
A61P 25/28A61K 38/063G01N 33/5023A61K 45/06G01N 33/5032A61K 31/198
64
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Compositions and Methods for the Treatment of Amyloid Deposit diseases, e.g., Hereditary cystatin C amyloid angiopathy and other neurodegenerative disorders, are disclosed.

Claims

exact text as granted — not AI-modified
1 . A method for treating amyloid deposit disease comprising delivering an effective amount of at least one antioxidant to a patient at risk for amyloid disease. 
     
     
         2 - 22 . (canceled)

Join the waitlist — get patent alerts

Track US2022347255A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.